← Open Payments lookup

JENNA RICKENBAUGH: Open Payments

NPI 1841809696 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,563 in 102 payments from 15 companies in 2025. Trend: 2023 $1,555 · 2024 $1,254 · 2025 $1,563

Food & beverage: $1,563
CompanyPaymentsAmount
ABBVIE INC.44$583
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$240
PFIZER INC.9$152
Novo Nordisk Inc10$136
Otsuka America Pharmaceutical, Inc.6$111
GlaxoSmithKline, LLC.4$74
Axsome Therapeutics, Inc.3$58
Exact Sciences Corporation2$43
Lilly USA, LLC3$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$35

Products named: VRAYLAR, CAPLYTA, UBRELVY, REXULTI, Ozempic, QULIPTA, NURTEC ODT, SHINGRIX.

Industry payments across IN — which companies pay providers there.